Smarter, Faster Biologics Discovery with in Silico Modeling
Insighthub
Sponsored by:
eBooks
Transforming Biologics Discovery with AI and In Silico Modeling
Leverage BIOVIA Discovery Studio for Breakthroughs in Biopharma
Today’s biopharmaceutical landscape is characterized by its complexity, with a pressing demand for drugs that offer improved specificity, safety, and mechanisms of action against increasingly intricate disease profiles.
Case Studies
From Volume to Value: How Ipca Laboratories Scaled Compliant Lab Operations with BIOVIA ONE Lab
Ipca Laboratories Limited (Ipca) is a global pharmaceutical manufacturer operating 34 manufacturing sites and 8 R&D laboratories, managing over 15,000 API batches and 20,000 formulation batches annually.
Advancing Bispecific Antibody Development
Driving efficiency and safety in antibody discovery with in silico solutions